您的当前位置:首页 > 行业数据 > 国内处于临床阶段的泛FGFR抑制剂和FGFR1/2/3抑制剂
图片属性
图片格式:PNG 图片大小:264KB 图片尺寸:1926*1765
同报告图片
 / 4
国内处于临床阶段的泛FGFR抑制剂和FGFR1/2/3抑制剂_第1页
<table border="1" cellspacing="0" cellpadding="5">
    <thead>
        <tr style="background-color: #004080; color: white;">
            <th>药物名称</th>
            <th>公司名称</th>
            <th>适应症</th>
            <th>临床阶段</th>
            <th>首次公示日期</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td rowspan="3">Pemigatinib</td>
            <td rowspan="3">信达</td>
            <td>一线胆管癌</td>
            <td>递交上市申请</td>
            <td>2021/7/2</td>
        </tr>
        <tr>
            <td>二线胆管癌</td>
            <td>二期</td>
            <td>2019/12/27</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/12/23</td>
        </tr>
        <tr>
            <td rowspan="5">Erdafitinib</td>
            <td rowspan="5">强生</td>
            <td>二线尿路上皮癌</td>
            <td>三期</td>
            <td>2018/11/27</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>二期</td>
            <td>2017/7/5</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>二期</td>
            <td>2020/3/23</td>
        </tr>
        <tr>
            <td>非肌层浸润性膀胱肿瘤</td>
            <td>二期</td>
            <td>2020/9/15</td>
        </tr>
        <tr>
            <td>二线晚期肝细胞癌</td>
            <td>I/II期</td>
            <td>2017/7/25</td>
        </tr>
        <tr>
            <td rowspan="2">Infigratinib</td>
            <td rowspan="2">Alcami</td>
            <td>胆管癌</td>
            <td>三期</td>
            <td>2021/2/18</td>
        </tr>
        <tr>
            <td>胃癌或胃食管结合部腺癌</td>
            <td>二期</td>
            <td>2021/2/25</td>
        </tr>
        <tr>
            <td rowspan="3">HMPL - 453</td>
            <td rowspan="3">和黄医药</td>
            <td>晚期恶性复治间皮瘤</td>
            <td>二期</td>
            <td>2019/11/4</td>
        </tr>
        <tr>
            <td>晚期肝内胆管癌</td>
            <td>二期</td>
            <td>2020/5/22</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>I/II期</td>
            <td>2017/7/28</td>
        </tr>
        <tr>
            <td rowspan="2">ICP - 192</td>
            <td rowspan="2">诺诚健华</td>
            <td>尿路上皮癌</td>
            <td>二期</td>
            <td>2020/4/27</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>I/II期</td>
            <td>2018/11/22</td>
        </tr>
        <tr>
            <td>E7090</td>
            <td>卫材</td>
            <td>胆管癌</td>
            <td>二期</td>
            <td>2020/8/14</td>
        </tr>
        <tr>
            <td>Derazantinib</td>
            <td>仑胜医药</td>
            <td>胆管癌</td>
            <td>I/II期</td>
            <td>2019/5/27</td>
        </tr>
        <tr>
            <td rowspan="4">AL 8326</td>
            <td rowspan="4">爱德程医药</td>
            <td>小细胞肺癌</td>
            <td>I/II期</td>
            <td>2020/9/11</td>
        </tr>
        <tr>
            <td>妇科恶性肿瘤</td>
            <td>一期</td>
            <td>2021/1/18</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2018/12/12</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2017/2/3</td>
        </tr>
        <tr>
            <td rowspan="3">MAX 40279</td>
            <td rowspan="3">再极医药</td>
            <td>MDS，复发或难治性 AML</td>
            <td>I/II期</td>
            <td>2021/6/2</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/12/26</td>
        </tr>
        <tr>
            <td>复发难治性 AML</td>
            <td>一期</td>
            <td>2019/10/9</td>
        </tr>
        <tr>
            <td>BGJ398</td>
            <td>诺华</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2014/9/11</td>
        </tr>
        <tr>
            <td>EOC317</td>
            <td>亿腾景昂</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2018/4/9</td>
        </tr>
        <tr>
            <td>HH185</td>
            <td>上海海和、思路迪</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2018/10/23</td>
        </tr>
        <tr>
            <td>SYHA1803</td>
            <td>石药</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/6/28</td>
        </tr>
        <tr>
            <td>SC0011</td>
            <td>智康弘仁</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2021/2/18</td>
        </tr>
        <tr>
            <td>BPI - 17509</td>
            <td>贝达药业</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/10/23</td>
        </tr>
        <tr>
            <td rowspan="2">AL58805</td>
            <td rowspan="2">爱德程医药</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2021/4/15</td>
        </tr>
        <tr>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2019/1/14</td>
        </tr>
        <tr>
            <td>AZD 4547</td>
            <td>和誉生物</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2021/4/23</td>
        </tr>
        <tr>
            <td>HZB1006</td>
            <td>哈尔滨珍宝</td>
            <td>晚期实体瘤</td>
            <td>一期</td>
            <td>2021/5/25</td>
        </tr>
    </tbody>
</table>

<p>资料来源：丁香园，申万宏源研究</p>
国内处于临床阶段的泛FGFR抑制剂和FGFR1/2/3抑制剂_第2页
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
国内处于临床阶段的泛FGFR抑制剂和FGFR1/2/3抑制剂_第3页
PHRhYmxlPgogICAgPHRoZWFkPgogICAgICAgIDx0cj4KICAgICAgICAgICAgYGBgaHRtbAo8dGg+5o6S5ZCNPC90aD4KICAgICAgICAgICAgPHRoPuWVhuWTgeWQjTwvdGg+CiAgICAgICAgICAgIDx0aD7pgJrnlKjlkI08L3RoPgogICAgICAgICAgICA8dGg+5YWs5Y+45ZCN56ewPC90aD4KICAgICAgICAgICAgPHRoPjIwMjDlubTlhajnkIPplIDllK7pop3vvIjkur/nvo7lhYPvvIk8L3RoPgogICAgICAgIDwvdHI+CiAgICA8L3RoZWFkPgogICAgPHRib2R5PgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPjE8L3RkPgogICAgICAgICAgICA8dGQ+5L+u576O5LmQPC90ZD4KICAgICAgICAgICAgPHRkPumYv+i+vuacqOWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD7oib7kvK/nu7Q8L3RkPgogICAgICAgICAgICA8dGQ+MTk4PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPjI8L3RkPgogICAgICAgICAgICA8dGQ+5Y+v55Ge6L6+PC90ZD4KICAgICAgICAgICAgPHRkPuW4leWNmuWIqeePoOWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD7pu5jmspnkuJw8L3RkPgogICAgICAgICAgICA8dGQ+MTQ0PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPjM8L3RkPgogICAgICAgICAgICA8dGQ+55Ge5aSN576OPC90ZD4KICAgICAgICAgICAgPHRkPuadpemCo+W6puiDujwvdGQ+CiAgICAgICAgICAgIDx0ZD7nmb7ml7bnvo7mlr3otLXlrp08L3RkPgogICAgICAgICAgICA8dGQ+MTIxPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPjQ8L3RkPgogICAgICAgICAgICA8dGQ+5Lq/54+CPC90ZD4KICAgICAgICAgICAgPHRkPuS8iuW4g+abv+WwvDwvdGQ+CiAgICAgICAgICAgIDx0ZD7lvLrnlJ8v6Im+5Lyv57u0PC90ZD4KICAgICAgICAgICAgPHRkPjk0PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPjU8L3RkPgogICAgICAgICAgICA8dGQ+6Im+5LmQ5aalPC90ZD4KICAgICAgICAgICAgPHRkPumYv+WTjOaymeePrTwvdGQ+CiAgICAgICAgICAgIDx0ZD7ovonnkZ4v55m+5pe2576O5pa96LS15a6dPC90ZD4KICAgICAgICAgICAgPHRkPjkyPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPjY8L3RkPgogICAgICAgICAgICA8dGQ+6Im+5Yqb6ZuFPC90ZD4KICAgICAgICAgICAgPHRkPumYv+afj+ilv+aZrjwvdGQ+CiAgICAgICAgICAgIDx0ZD7mi5zogLMv5YaN55Sf5YWDPC90ZD4KICAgICAgICAgICAgPHRkPjc5PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPjc8L3RkPgogICAgICAgICAgICA8dGQ+5qyn54uE5rKDPC90ZD4KICAgICAgICAgICAgPHRkPue6s+atpuWIqeWwpOWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD7nmb7ml7bnvo7mlr3otLXlrp08L3RkPgogICAgICAgICAgICA8dGQ+Nzg8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+ODwvdGQ+CiAgICAgICAgICAgIDx0ZD7llpzovr7or7o8L3RkPgogICAgICAgICAgICA8dGQ+5LmM5Y+45aW05Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPuadqOajrjwvdGQ+CiAgICAgICAgICAgIDx0ZD43NzwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD45PC90ZD4KICAgICAgICAgICAgPHRkPuaLnOeRnuWmpTwvdGQ+CiAgICAgICAgICAgIDx0ZD7liKnkvJDmspnnj608L3RkPgogICAgICAgICAgICA8dGQ+5ouc6ICzPC90ZD4KICAgICAgICAgICAgPHRkPjc1PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPjEwPC90ZD4KICAgICAgICAgICAgPHRkPuW/heWmpee7tDwvdGQ+CiAgICAgICAgICAgIDx0ZD7mr5TlhYvmgankuJnor7o8L3RkPgogICAgICAgICAgICA8dGQ+5ZCJ5Yip5b63PC90ZD4KICAgICAgICAgICAgPHRkPjczPC90ZD4KICAgICAgICA8L3RyPgogICAgPC90Ym9keT4KPC90YWJsZT4KCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOS4reS4h+Wuj+a6kOeglOeptgpgYGA=
国内处于临床阶段的泛FGFR抑制剂和FGFR1/2/3抑制剂_第4页
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
国内处于临床阶段的泛FGFR抑制剂和FGFR1/2/3抑制剂_第5页
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
所属报告: 诺诚健华-奥布替尼商业化元年Biopharma雏形初显-210816(28页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠